RFA-AI-22-076: Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on June 9, 2023.
From the official notice on Grants.gov, last changed February 7, 2023. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeU01
- Clinical trialsRequired
- Funded byNIAID
- Median yearly award$384,995
- Typical project length7 years
- U01, Research Project Cooperative Agreement. Like an R01, but NIH staff are substantially involved in the work. Other open U01 notices.
Projects funded under RFA-AI-22-076 were run by National Institute of Allergy and Infectious Diseases (NIAID, 10 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-AI-22-076 in the NIH Guide.
Key dates
| Posted | February 7, 2023 |
|---|---|
| Deadline | June 9, 2023 |
| Archived by Grants.gov | July 15, 2023 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (67% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Clinical Research Centers (CRC) for the NIAID Consortium for Food Allergy Research (CoFAR). The CoFAR-CRCs will conduct both network-wide observational studies/clinical trials and center-specific projects with the goals to advance prevention and management strategies and to improve knowledge on the origins and the pathophysiology of IgE-mediated food allergy, Alpha-Gal Syndrome, Food Protein-induced Enterocolitis Syndrome and Eosinophilic Esophagitis. For network-wide clinical research projects and other network functions, the CoFAR-CRCs will work closely with the CoFAR Leadership Center (CoFAR-LC). The CoFAR CRCs also will conduct center-specific human research projects.
Funded under RFA-AI-22-076 so far
NIH funded 10 projects under RFA-AI-22-076 in fiscal 2024 to 2026, at 10 institutions. The median yearly award was $384,995.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Consortium for food allergy research clinical center CoFar | Boston Children's Hospital | 2026 | $380,000 |
| Mount Sinai's CoFAR Clinical Research Center | Icahn School of Medicine at Mount Sinai | 2026 | $399,999 |
| Northwestern University CoFAR (NU-CoFAR) Clinical Research Center | Northwestern University | 2026 | $389,990 |
| University of Michigan MHWFAC CoFar CMC Center Application | University of Michigan at Ann Arbor | 2026 | $380,000 |
| Consortium of Food Allergy Research Clinical Research Center at Cincinnati Children's Hospital Medical Center (CoFAR-CRC:CCHMC) | Cincinnati Childrens Hosp Med Ctr | 2026 | $380,000 |
| Arkansas Center for Food Allergy Research (ArCOFAR) | Arkansas Children's Hospital Res Inst | 2026 | $640,028 |
| Clinical Research Unit: Johns Hopkins University | Johns Hopkins University | 2026 | $390,000 |
| UNC Food Allergy Initiative | Univ of North Carolina Chapel Hill | 2026 | $390,000 |
Who has won Allergy and Infectious Diseases Research grants before
From fiscal 2021 to 2025, Allergy and Infectious Diseases Research (93.855) awarded $22 billion across 13,282 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Washington | 85 | $938 million |
| Duke University | North Carolina | 230 | $781 million |
| University of California, Los Angeles | California | 138 | $745 million |
| The Johns Hopkins University | Maryland | 321 | $668 million |
| Emory University | Georgia | 282 | $650 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-AI-22-076 still open?
No. It closed on June 9, 2023.
Who can apply for Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)?
Closed June 9, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-AI-22-076?
NIH RePORTER lists 10 projects funded under RFA-AI-22-076 in fiscal 2024 to 2026, at 10 institutions. The most were at Boston Children's Hospital, Icahn School of Medicine at Mount Sinai, Northwestern University.
Who has won Allergy and Infectious Diseases Research grants before?
The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
- Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional)